These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

800 related articles for article (PubMed ID: 34872596)

  • 41. Health-related quality of life in subjective cognitive decline and mild cognitive impairment: a longitudinal cohort analysis.
    Aye S; Bouteloup V; Tate A; Wimo A; Handels R; Jean D; Winblad B; Jönsson L
    Alzheimers Res Ther; 2023 Nov; 15(1):200. PubMed ID: 37968734
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening for mild cognitive impairment (MCI) utilizing combined mini-mental-cognitive capacity examinations for identifying dementia prodromes.
    Xu G; Meyer JS; Thornby J; Chowdhury M; Quach M
    Int J Geriatr Psychiatry; 2002 Nov; 17(11):1027-33. PubMed ID: 12404652
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Associations of MRI-visible perivascular spaces with longitudinal cognitive decline across the Alzheimer's disease spectrum.
    Wang ML; Zou QQ; Sun Z; Wei XE; Li PY; Wu X; Li YH;
    Alzheimers Res Ther; 2022 Dec; 14(1):185. PubMed ID: 36514127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development, Application, and Results from a Precision-medicine Platform that Personalizes Multi-modal Treatment Plans for Mild Alzheimer's Disease and At-risk Individuals.
    Keine D; Walker JQ; Kennedy BK; Sabbagh MN
    Curr Aging Sci; 2018; 11(3):173-181. PubMed ID: 30338750
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparing a pre-defined versus deep learning approach for extracting brain atrophy patterns to predict cognitive decline due to Alzheimer's disease in patients with mild cognitive symptoms.
    Arvidsson I; Strandberg O; Palmqvist S; Stomrud E; Cullen N; Janelidze S; Tideman P; Heyden A; Åström K; Hansson O; Mattsson-Carlgren N
    Alzheimers Res Ther; 2024 Mar; 16(1):61. PubMed ID: 38504336
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brief Cognitive Tests Used in Primary Care Cannot Accurately Differentiate Mild Cognitive Impairment from Subjective Cognitive Decline.
    Petrazzuoli F; Vestberg S; Midlöv P; Thulesius H; Stomrud E; Palmqvist S
    J Alzheimers Dis; 2020; 75(4):1191-1201. PubMed ID: 32417771
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
    Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
    JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment.
    Alegret M; Cuberas-Borrós G; Espinosa A; Valero S; Hernández I; Ruíz A; Becker JT; Rosende-Roca M; Mauleón A; Sotolongo O; Castell-Conesa J; Roca I; Tárraga L; Boada M
    J Alzheimers Dis; 2014; 41(3):739-48. PubMed ID: 24685632
    [TBL] [Abstract][Full Text] [Related]  

  • 50. White matter disease independently predicts progression from mild cognitive impairment to Alzheimer's disease in a clinic cohort.
    Prasad K; Wiryasaputra L; Ng A; Kandiah N
    Dement Geriatr Cogn Disord; 2011; 31(6):431-4. PubMed ID: 21757908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Study partner-reported decline identifies cognitive decline and dementia risk.
    Nosheny RL; Jin C; Neuhaus J; Insel PS; Mackin RS; Weiner MW;
    Ann Clin Transl Neurol; 2019 Dec; 6(12):2448-2459. PubMed ID: 31721455
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Montreal Cognitive Assessment is superior to the Mini-Mental State Examination in detecting patients at higher risk of dementia.
    Dong Y; Lee WY; Basri NA; Collinson SL; Merchant RA; Venketasubramanian N; Chen CL
    Int Psychogeriatr; 2012 Nov; 24(11):1749-55. PubMed ID: 22687278
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Memory performance on the story recall test and prediction of cognitive dysfunction progression in mild cognitive impairment and Alzheimer's dementia.
    Park JH; Park H; Sohn SW; Kim S; Park KW
    Geriatr Gerontol Int; 2017 Oct; 17(10):1603-1609. PubMed ID: 27910252
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors of cognitive impairment in an early stage Parkinson's disease cohort.
    Hu MT; Szewczyk-Królikowski K; Tomlinson P; Nithi K; Rolinski M; Murray C; Talbot K; Ebmeier KP; Mackay CE; Ben-Shlomo Y
    Mov Disord; 2014 Mar; 29(3):351-9. PubMed ID: 24395708
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia.
    Kile S; Au W; Parise C; Rose K; Donnel T; Hankins A; Chan M; Ghassemi A
    J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):106-112. PubMed ID: 26420886
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patterns of Cognitive Decline Prior to Dementia in Persons with Mild Cognitive Impairment.
    Cloutier S; Chertkow H; Kergoat MJ; Gauthier S; Belleville S
    J Alzheimers Dis; 2015; 47(4):901-13. PubMed ID: 26401770
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
    Nogueira J; Freitas S; Duro D; Almeida J; Santana I
    Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predicting Mental Decline Rates in Mild Cognitive Impairment From Baseline MRI Volumetric Data.
    Nguyen XV; Candemir S; Erdal BS; White RD; Prevedello LM
    Alzheimer Dis Assoc Disord; 2021 Jan-Mar 01; 35(1):1-7. PubMed ID: 32925201
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.
    Julayanont P; Brousseau M; Chertkow H; Phillips N; Nasreddine ZS
    J Am Geriatr Soc; 2014 Apr; 62(4):679-84. PubMed ID: 24635004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.